CRISPR Therapeutics AG (CRSP)
$53.39+5.85%Close
SELLBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV28.4%–102.0%
- Market cap
- $5.1B
- Beta
- 1.76
- P/E (TTM)
- -11.34
- IV-%ile
- 35
- IV ATM
- 56.6%
- Short % float
- 19.45%
- Days to cover
- 9.6
- SI change
- -2.0%
- 1W
- -3.68%
- 1M
- +2.16%
- vs SPY 1W
- -4.84%
- vs SPY 1M
- -0.83%
Industry peers
FMP comparable companies · ranked by market cap
- PCVXBUYVaxcyte, Inc.$10.7BRECOVERYQ 26$73.82+9.78%
- KRYSSELLKrystal Biotech, Inc.$9.9BBEARQ 46$334.85+1.32%
- NUVLBUYNuvalent, Inc.$9.1BBULLQ 42$123.96+0.00%
- ARWRSELLArrowhead Pharmaceuticals, Inc.$8.8BCRISISQ 12$62.35+3.31%
- TGTXSELLTG Therapeutics, Inc.$8.3BBEARQ 11$53.91+3.81%
- CYTKSELLCytokinetics, Incorporated$7.8BCRISISQ 9$62.70+1.45%
- MTSRMetsera, Inc.$7.4B$70.50
- ACLXArcellx, Inc.$6.7B$115.07
- PTCTSELLPTC Therapeutics, Inc.$5.3BRECOVERYQ 18$63.65+3.42%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CRSP?
- LOPJLB’s latest quantitative signal on CRISPR Therapeutics AG (CRSP) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is CRSP in?
- CRISPR Therapeutics AG (CRSP) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does CRISPR Therapeutics AG (CRSP) do?
- CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code. Its extensive pipeline includes thera…